Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
1.035
-0.015 (-1.43%)
May 30, 2025, 1:49 PM - Market open
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $42.52 million as of May 30, 2025. Its market cap has decreased by -43.46% in one year.
Market Cap
42.52M
Enterprise Value
29.86M
1-Year Change
-43.46%
Ranking
Category
Stock Price
$1.04
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $42.52M, a decrease of -73.89%. That is a compound annual growth rate of -28.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 43.14M | -0.98% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -11.85% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 651.73B |
| Johnson & Johnson | 370.15B |
| AbbVie | 328.32B |
| Novo Nordisk | 313.75B |
| UnitedHealth Group | 265.60B |
| Abbott Laboratories | 231.57B |
| Novartis AG | 224.07B |
| AstraZeneca | 219.48B |